Published in Skin Pharmacol Appl Skin Physiol on October 06, 2003
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. AIDS (2001) 3.35
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther (2000) 3.14
Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. Arch Intern Med (2000) 2.11
Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm (2000) 1.58
Maintaining skin integrity in the aged: a systematic review. Br J Dermatol (2013) 1.47
Buschke-Ollendorff syndrome--differential diagnosis of disseminated connective tissue lesions. Eur J Dermatol (2001) 1.47
Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study. Br J Dermatol (2014) 1.39
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clin Infect Dis (2012) 1.36
Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.32
Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release (2000) 1.21
Intra-abdominal Candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality. Crit Care Med (1998) 1.20
Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol (2004) 1.19
Matting of hair: a multifactorial enigma. Dermatology (2000) 1.16
Hair follicles--an efficient storage and penetration pathway for topically applied substances. Summary of recent results obtained at the Center of Experimental and Applied Cutaneous Physiology, Charité -Universitätsmedizin Berlin, Germany. Skin Pharmacol Physiol (2008) 1.12
The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol (2007) 1.12
Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy. J Infect Dis (2001) 1.12
An improved high-performance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials. Naunyn Schmiedebergs Arch Pharmacol (2001) 1.11
Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol (2004) 1.05
Stabilities of free and complexed human immunodeficiency virus p24 antigens during short- and long-term storage. J Clin Microbiol (1997) 1.05
[The short version of the Brief Symptom Inventory (BSI -18): preliminary psychometric properties of the German translation]. Fortschr Neurol Psychiatr (2011) 1.05
1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol (2001) 0.99
An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol (2013) 0.99
Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers. Antimicrob Agents Chemother (1987) 0.99
Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole. Antimicrob Agents Chemother (1993) 0.98
Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle. Arch Dermatol Res (1998) 0.98
Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin. Arch Dermatol (1992) 0.95
Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol In Vitro (2005) 0.95
Stratum corneum maturation. A review of neonatal skin function. Skin Pharmacol Physiol (2004) 0.95
Barriers to bicycle helmet use among Dutch paediatricians. Child Care Health Dev (2008) 0.95
Cefodizime penetration into skin suction blister fluid following a single intravenous dose. Eur J Clin Pharmacol (1986) 0.95
Fulminant metastatic calcinosis with cutaneous necrosis in a child with end-stage renal disease and tertiary hyperparathyroidism. Br J Dermatol (1996) 0.95
Atenolol interaction with aspirin, allopurinol, and ampicillin. Clin Pharmacol Ther (1983) 0.94
Measuring quality of life in early HIV disease: the modular approach. Qual Life Res (1997) 0.93
Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120. AIDS Res Hum Retroviruses (1998) 0.92
Metastatic Crohn's disease of the face. J Am Acad Dermatol (1996) 0.91
Interaction kinetics of tetramethylrhodamine transferrin with human transferrin receptor studied by fluorescence correlation spectroscopy. Biochemistry (1999) 0.90
The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker. AIDS (1998) 0.90
Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release (2005) 0.90
Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses (2005) 0.90
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group. AIDS Res Hum Retroviruses (2000) 0.89
UD-CG 115--a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.89
Regulation of PDGF and PDGF receptor in cultured dermal papilla cells and follicular keratinocytes of the human hair follicle. Exp Dermatol (2003) 0.89
Isokinetic muscle performance in healthy female handball players and players with a unilateral anterior cruciate ligament reconstruction. Scand J Med Sci Sports (1996) 0.89
Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm (2000) 0.88
RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie (2005) 0.88
Effect of 5alpha-dihydrotestosterone and testosterone on apoptosis in human dermal papilla cells. Skin Pharmacol Physiol (2006) 0.87
Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target (2002) 0.87
Human plasma and skin blister fluid levels of griseofulvin following a single oral dose. Eur J Clin Pharmacol (1985) 0.87
Hair follicles - a long-term reservoir for drug delivery. Skin Pharmacol Physiol (2006) 0.86
[Follicular penetration. An important pathway for topically applied substances]. Hautarzt (2003) 0.86
Performance enhancing drugs (doping agents) and sudden death--a case report and review of the literature. Int J Legal Med (1998) 0.86
Interaction of fluorescence labeled single-stranded DNA with hexameric DNA-helicase RepA: a photon and fluorescence correlation spectroscopy study. Biochemistry (2001) 0.85
Ketoconazole concentrations in human skin blister fluid and plasma. Int J Clin Pharmacol Ther Toxicol (1984) 0.85
Influence of bathing or washing on skin barrier function in newborns during the first four weeks of life. Skin Pharmacol Physiol (2009) 0.85
Does cantharides blister fluid provide access to the peripheral compartment? Eur J Clin Pharmacol (1982) 0.85
Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1. Clin Pharmacol Ther (1996) 0.85
Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release. Br J Pharmacol (1997) 0.84
[Antimicrobial effects of in vitro-simulated ketoconazole-cantharidin blister fluid levels on candida albicans]. Mykosen (1986) 0.84
Glucocorticoids mediate differential anti-apoptotic effects in human fibroblasts and keratinocytes via sphingosine-1-phosphate formation. J Cell Biochem (2004) 0.83
Ultraviolet radiation and nanoparticle induced intracellular free radicals generation measured in human keratinocytes by electron paramagnetic resonance spectroscopy. Skin Res Technol (2013) 0.83
Pharmacokinetics of hydrochlorothiazide in relation to renal function. Eur J Clin Pharmacol (1983) 0.83
Evidence of heterogeneity and quantitative differences of the type 1 5alpha-reductase expression in cultured human skin cells--evidence of its presence in melanocytes. J Invest Dermatol (1998) 0.83
De novo expression of the alpha5beta1-fibronectin receptor in HT29 colon-cancer cells reduces activity of C-SRC. Increase of C-SRC activity by attachment on fibronectin. Int J Cancer (1998) 0.83
Monitoring of isotretinoin therapy by measuring the plasma levels of isotretinoin and 4-oxo-isotretinoin. A useful tool for management of severe acne. Dermatology (1998) 0.83
Toxoplasmosis in Sand cats (Felis margarita) and other animals in the Breeding Centre for Endangered Arabian Wildlife in the United Arab Emirates and Al Wabra Wildlife Preservation, the State of Qatar. Vet Parasitol (2010) 0.83
Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Release (2004) 0.83
Clinical experience with atenolol in patients with chronic liver disease. J Clin Pharmacol (1983) 0.82
Human plasma and skin blister fluid levels of griseofulvin after its repeated administration. Eur J Clin Pharmacol (1985) 0.82
Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging. Skin Pharmacol Physiol (2004) 0.82
Guess what! Eruptive vellus hair cysts. Eur J Dermatol (2000) 0.82
Intraindividual variations of 8-methoxypsoralen plasma levels. Arch Dermatol Res (1982) 0.82
In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans. Mycoses (2006) 0.82
Blistering time as a parameter for the strength of dermoepidermal adhesion: a systematic review and meta-analysis. Br J Dermatol (2014) 0.82
Functional characterisation of MeCP2 mutations found in male patients with X linked mental retardation. J Med Genet (2002) 0.82
Melkersson-Rosenthal syndrome in childhood: a challenge in differential diagnosis and treatment. Br J Dermatol (2000) 0.82
Sphingosine 1-phosphate is involved in cytoprotective actions of calcitriol in human fibroblasts and enhances the intracellular Bcl-2/Bax rheostat. Pharmazie (2005) 0.81
Spatial patterns of mitochondrial and nuclear gene pools in chamois (Rupicapra r. rupicapra) from the Eastern Alps. Heredity (Edinb) (2003) 0.81
Cultured dermal papilla cells of the rat vibrissa follicle. Proliferative activity, adhesion properties and reorganization of the extracellular matrix in vitro. Arch Dermatol Res (1997) 0.81
Characterisation of epidermal regeneration in vivo: a 60-day follow-up study. J Wound Care (2013) 0.80
New insights on dandruff/seborrhoeic dermatitis: the role of the scalp follicular infundibulum in effective treatment strategies. Br J Dermatol (2011) 0.80
[Penetration of microparticles into human skin]. Hautarzt (2004) 0.80
The Phenion full-thickness skin model for percutaneous absorption testing. Skin Pharmacol Physiol (2009) 0.80
[Biology of the human hair follicle. New knowledge and the clinical significance]. Hautarzt (2003) 0.80
Basal cell carcinoma possibly originates from the outer root sheath and/or the bulge region of the vellus hair follicle. Arch Dermatol Res (1999) 0.80
Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography. Br J Dermatol (2012) 0.80
Nodular and bullous cutaneous mastocytosis of the xanthelasmoid type: case report. Br J Dermatol (2001) 0.80
Interocular equality of tonic accommodation and consensuality of accommodative hysteresis. Ophthalmic Physiol Opt (1987) 0.80
Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea. Int J Clin Pharmacol Ther Toxicol (1984) 0.80
Interaction of atenolol with furosemide and calcium and aluminum salts. Clin Pharmacol Ther (1981) 0.79
Androgen responsive genes as they affect hair growth. Eur J Dermatol (2001) 0.79
Can a regular leg extension bench be used in testing deficits of the quadriceps muscle during rehabilitation? Scand J Med Sci Sports (1995) 0.79
Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro. Pharm Res (1997) 0.79
[Kaposiform HHV-8 negative acroangiodermatitis in chronic venous insufficiency]. Hautarzt (1999) 0.79
Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.79
Vascular endothelial growth factor expression induced by proinflammatory cytokines (interleukin 1 alpha, beta) in cells of the human pilosebaceous unit. Dermatology (1998) 0.79
Skin blister fluid levels of ketoconazole during repetitive administration in healthy man. Mycoses (1989) 0.79